Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2259.5%
Neutral1335.1%
Bearish25.4%
BorgWarner Inc. · BWA · FY2025 Q3 · Calendar Q4 2025
BorgWarner raises 2025 guidance as new awards offset operational risks
BorgWarner's Q3 results and raised 2025 outlook support a constructive near-term operating picture, with new awards and cost discipline providing support. The case remains exposed to supply disruption, customer downtime, battery-system weakness and EV program volatility.
Reported Before market openNYSEConsumer Cyclical
$10.37B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.24
Consensus $1.16
EPS surprise
+6.9%
Reported versus consensus
Reported revenue
$3.59B
Consensus $3.48B
Revenue surprise
+3.1%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+3.1%
Event window
SPY move
-1.1%
Same window
Abnormal move
+4.2%
Stock minus SPY
Volume
1.9×
Versus trailing sessions
Subsequent drift
-2.4%
Up to 20 sessions
BWASPY benchmark
Ask FN2 about BWA FY2025 Q3
Transcript, numbers and history already loaded
Why did BWA rise 3.1% after beating EPS estimates in FY2025 Q3?What changed in BWA's guidance and outlook in FY2025 Q3?Give me the bull and bear case for BWA after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with Q2, management again raised full-year 2025 guidance and pointed to a broad set of new awards. Q3 results included margin expansion and strong free cash flow, but the call also identified a European customer cyber shutdown and Nexperia-related semiconductor constraints as operating risks.
Guidance delta
Management raised full-year 2025 sales guidance to $14.1–$14.3 billion, adjusted operating margin to 10.3–10.5%, and EPS to $4.60–$4.75; free-cash-flow guidance was also raised, with no revised range supplied in the analysis.
Key takeaways
- Q3 results beat expectations, with organic sales up just over 2% and adjusted operating margin rising 60 basis points to 10.7%.
- Free cash flow rose 32% to $266 million; more than $136 million was returned to shareholders.
- New awards span turbochargers, e-products and battery systems, including programs with Chery, Stellantis, Great Wall Motor and HOLON Urban.
- Management cited cost controls, a strong quoting environment and expected tariff recovery as support for performance.
Management priorities
- Scale awarded foundational and electrified powertrain programs, including eVCT, integrated drive modules and battery systems.
- Continue cost-control and productivity efforts while managing tariff recovery and semiconductor supply constraints.
- Pursue selective acquisitions that meet industrial-logic and accretion criteria, alongside shareholder returns.
Follow BWA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$51.63Previous close
$36Low
$63.12Average
$95High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 30, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 30, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Oct 15, 2026 |
| UBS | Buy | Buy | Maintain | Oct 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 2, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Mar 25, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 17, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 12, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Feb 12, 2026 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jan 8, 2026 |
| Baird | Outperform | Neutral | Upgrade | Sep 3, 2025 |
| Guggenheim | Buy | Buy | Maintain | Apr 22, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Jul 12, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | May 3, 2024 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Feb 20, 2024 |
| Nomura Instinet | Neutral | Buy | Downgrade | Aug 17, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | May 5, 2022 |
| Jefferies | Hold | Buy | Downgrade | Sep 20, 2021 |
| Keybanc | Overweight | Overweight | Maintain | Apr 21, 2021 |
| CFRA | Buy | Hold | Upgrade | Mar 31, 2020 |
| Nomura | Buy | Buy | Maintain | Aug 27, 2019 |
| Seaport Global | Neutral | Neutral | Maintain | Feb 13, 2019 |
| Bank of America | Neutral | Underperform | Upgrade | Oct 23, 2018 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 3, 2018 |
| Buckingham | Neutral | Neutral | Maintain | Oct 3, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Apr 16, 2018 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 30, 2017 |
| Berenberg | Sell | Sell | Maintain | Nov 22, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Feb 16, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Feb 16, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Jan 14, 2016 |
| Susquehanna | Positive | Positive | Maintain | Aug 27, 2015 |
| Northcoast Research | Buy | Buy | Maintain | Jul 8, 2015 |
| Gabelli & Co. | Buy | Hold | Upgrade | Oct 14, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $51.63. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $91 | $63.36 | +76.3% | Oct 7, 2026 |
| Morgan Stanley | Andrew Percoco | $95 | $60.26 | +84.0% | Oct 6, 2026 |
| RBC Capital | Tom Narayan | $87 | $64.16 | +68.5% | Aug 31, 2026 |
| Barclays | Analyst unavailable | $85 | $68.42 | +64.6% | Aug 10, 2026 |
| Robert W. Baird | Luke Junk | $79 | $67.46 | +53.0% | Aug 6, 2026 |
| Deutsche Bank | Analyst unavailable | $80 | $67.66 | +54.9% | Aug 6, 2026 |
| Morgan Stanley | Andrew Percoco | $71 | $66.78 | +37.5% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $83 | $65.7 | +60.8% | Jul 9, 2026 |
| Goldman Sachs | Analyst unavailable | $84 | $71.29 | +62.7% | Jun 11, 2026 |
| UBS | Joseph Spak | $95 | $73.27 | +84.0% | Jun 10, 2026 |
| Wolfe Research | Emmanuel Rosner | $95 | $76.54 | +84.0% | Jun 3, 2026 |
| Wells Fargo | Analyst unavailable | $83 | $71.06 | +60.8% | Jun 2, 2026 |
| Morgan Stanley | Andrew Percoco | $67 | $68.26 | +29.8% | May 27, 2026 |
| UBS | Joseph Spak | $61 | $58.63 | +18.1% | May 7, 2026 |
| Barclays | Analyst unavailable | $75 | $59.41 | +45.3% | May 7, 2026 |
| Deutsche Bank | Analyst unavailable | $81 | $55.11 | +56.9% | Apr 21, 2026 |
| UBS | Analyst unavailable | $56 | $53.56 | +8.5% | Apr 14, 2026 |
| UBS | Analyst unavailable | $55 | $60.31 | +6.5% | Feb 20, 2026 |
| Evercore ISI | Analyst unavailable | $75 | $62.8 | +45.3% | Feb 17, 2026 |
| New Street | Analyst unavailable | $66 | $68.8 | +27.8% | Feb 12, 2026 |
| Goldman Sachs | Analyst unavailable | $78 | $67.79 | +51.1% | Feb 12, 2026 |
| Barclays | Dan Levy | $70 | $66.1 | +35.6% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $60 | $66.1 | +16.2% | Feb 12, 2026 |
| Robert W. Baird | Analyst unavailable | $76 | $66.1 | +47.2% | Feb 12, 2026 |
| Wells Fargo | Analyst unavailable | $75 | $66.1 | +45.3% | Feb 12, 2026 |
| Deutsche Bank | Analyst unavailable | $82 | $66.1 | +58.8% | Feb 12, 2026 |
| Robert W. Baird | Luke Junk | $55 | $48.35 | +6.5% | Jan 14, 2026 |
| UBS | Analyst unavailable | $49 | $48.15 | -5.1% | Jan 14, 2026 |
| Piper Sandler | Analyst unavailable | $51 | $47.45 | -1.2% | Jan 8, 2026 |
| Morgan Stanley | Analyst unavailable | $49 | $43.3 | -5.1% | Dec 8, 2025 |
| Evercore ISI | Chris McNally | $53 | $42.68 | +2.7% | Nov 24, 2025 |
| Robert W. Baird | Luke Junk | $54 | $43.64 | +4.6% | Oct 31, 2025 |
| Barclays | Dan Levy | $55 | $41.64 | +6.5% | Oct 10, 2025 |
| UBS | Joseph Spak | $46 | $44.66 | -10.9% | Oct 6, 2025 |
| Goldman Sachs | Analyst unavailable | $52 | $44.04 | +0.7% | Sep 29, 2025 |
| Wells Fargo | Analyst unavailable | $50 | $43.69 | -3.2% | Sep 9, 2025 |
| Guggenheim | Analyst unavailable | $38 | $29.19 | -26.4% | Mar 5, 2025 |
| Morgan Stanley | Analyst unavailable | $40 | $28.83 | -22.5% | Mar 3, 2025 |
| Deutsche Bank | Edison Yu | $36 | $32.88 | -30.3% | Sep 9, 2024 |
| Robert W. Baird | David Leiker | $40 | $35.63 | -22.5% | May 3, 2024 |
| Barclays | Luke Junk | $44 | $35.61 | -14.8% | Apr 10, 2024 |
| Piper Sandler | Alexander Potter | $43 | $32.03 | -16.7% | Mar 14, 2024 |
| Citigroup | Analyst unavailable | $46 | $44.61 | -10.9% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $54 | $41.54 | +4.6% | Dec 7, 2022 |
| Morgan Stanley | Adam Jonas | $45 | $42.24 | -12.8% | Nov 28, 2022 |
| Morgan Stanley | Analyst unavailable | $32 | $39.04 | -38.0% | Aug 4, 2022 |
| RBC Capital | Analyst unavailable | $48 | $39.06 | -7.0% | Aug 4, 2022 |
| Robert W. Baird | Analyst unavailable | $44 | $39.34 | -14.8% | Aug 4, 2022 |
| Citigroup | Analyst unavailable | $45 | $39.51 | -12.8% | Aug 4, 2022 |
| Wells Fargo | Analyst unavailable | $57 | $34.5 | +10.4% | Jul 11, 2022 |
| Goldman Sachs | Mark Delaney | $40 | $35.52 | -22.5% | Jun 14, 2022 |
| Morgan Stanley | Analyst unavailable | $30 | $39.92 | -41.9% | Jun 1, 2022 |
| Credit Suisse | Dan Levy | $45 | $38.98 | -12.8% | May 5, 2022 |
| Deutsche Bank | Emmanuel Rosner | $44 | $36.51 | -14.8% | Apr 26, 2022 |
| Citigroup | Itay Michaeli | $43 | $36.41 | -16.7% | Apr 9, 2022 |
| Deutsche Bank | Emmanuel Rosner | $53 | $45.04 | +2.7% | Feb 16, 2022 |
| Bank of America Securities | John Murphy | $65 | $48.5 | +25.9% | Jan 6, 2022 |
| Nomura | Anindya Das | $58 | $45.32 | +12.3% | Aug 10, 2021 |
| Evercore ISI | Chris McNally | $50 | $46.21 | -3.2% | Aug 4, 2021 |
| KeyBanc | James Picariello | $60 | $49.39 | +16.2% | Apr 21, 2021 |
Track every rating change on BWA the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationBorgWarner Inc. (BWA) is a prominent global supplier of advanced propulsion technologies, catering to a wide spectrum of vehicles including those powered by internal combustion engines, hybrids, and fully electric drivetrains. The company's operations are divided into four primary business units: Air Management, E-Propulsion & Drivetrain, Fuel Injection, and Aftermarket. The Air Management segment is responsible for components that optimize engine performance and thermal control. This includes various turbocharging solutions (such as turbochargers, eBoosters, and eTurbos), engine timing and emissions control systems, thermal management products, gasoline ignition technology, smart actuators, powertrain sensors, and a range of battery-related items like modules, packs, heaters, and charging systems. The E-Propulsion & Drivetrain segment focuses on electrical powertrains and power transmission.…
Historical context
All BWA earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MGA Magna International Inc. | FY2026 Q3 · Calendar Q4 2026 | +15.8% | -1.4% | Magna expands margins as China production weighs on sales outlook |
| H Hyatt Hotels Corporation | FY2026 Q3 · Calendar Q4 2026 | +67.1% | +6.3% | Hyatt raises RevPAR and fee-growth outlook after strong Q3 |
| LTH Life Time Group Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | +25.9% | +5.1% | Life Time Group Raises Guidance as Growth Broadens |
| SBUX Starbucks Corporation | FY2026 Q4 · Calendar Q4 2026 | +11.3% | -1.7% | Starbucks posts resilient comps and sets FY27 margin targets |
| RIVN Rivian Automotive, Inc. | FY2026 Q3 · Calendar Q4 2026 | +25.4% | +6.2% | Rivian’s R2 scale-up lifted Q3 output and software momentum |
| AMZN Amazon.com, Inc. | FY2026 Q3 · Calendar Q4 2026 | -4.1% | -1.6% | Amazon pairs accelerating AWS AI demand with sustained capital intensity |
Latest beats and misses
Who reports nextBeat on EPS
- CHDFY2026 Q3 · October 30, 2026+2.2% EPS+1.2% move
- AZNFY2026 Q3 · October 30, 2026+7.3% EPS+7.0% move
- FRTFY2026 Q3 · October 30, 2026+3.9% EPS-1.1% move
- CVXFY2026 Q3 · October 30, 2026+8.4% EPS+1.8% move
- BTSGFY2026 Q3 · October 30, 2026+14.2% EPS+11.1% move
- EXCFY2026 Q3 · October 30, 2026+10.4% EPS+0.5% move
Missed on EPS
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
- VALEFY2026 Q3 · October 29, 2026-24.6% EPS+1.9% move
- DLR-PLFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLR-PKFY2026 Q3 · October 29, 2026-8.4% EPS— move
Get the BWA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-02T09:10:44.666967+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T09:10:44.664214+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.